+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID06840314

Study Comparing a New Vibrating Pelvic Floor Device to Traditional Vaginal Dilators for Improving Sexual Function in Women with Genito-Pelvic Pain and Penetration Disorder

Led by Medstar Health Research Institute · Updated on 2025-05-21

60

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating whether a new vibrating pelvic floor device called the Kiwi improves sexual function better than traditional vaginal dilators in sexually active women aged 18 and older with genito-pelvic pain and penetration disorder GPPPD. This randomized controlled trial aims to compare improvements in sexual function, distress, pain, and overall symptom severity between the two treatments. Participants will be randomly assigned to use either the Kiwi device or a standard set of graduated silicone vaginal dilators. They will use their assigned device three times a week for 15 minutes per session over four weeks. The Kiwi device offers vibration and multiple massage options, while traditional dilators provide progressive sizing without vibration. During the study, participants will complete surveys before and after the four-week period to assess sexual function, pain levels, distress, and symptom improvement using validated questionnaires. The main measure is the Female Sexual Function Index FSFI score after four weeks. This study lasts four weeks, with data collected at the start and end to evaluate treatment effects.

CONDITIONS

Brief Title

VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

Research Team

H

Helen Y Zhang, MD

E

Eun Sook Choi, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here